THE EFFECT OF THE COVID-19 PANDEMIC AND SOCIAL RESTRICTIONS ON
Article Sidebar
Published:
Nov 15, 2022
Keywords:
COVID-19, health services, blood transfusion
Main Article Content
Abstract
Background:
Article Details
How to Cite
Rakasiwi, M. (2022). THE EFFECT OF THE COVID-19 PANDEMIC AND SOCIAL RESTRICTIONS ON. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 10(1), 22-34. https://doi.org/10.53366/jimki.v10i1.512
Section
Article Review
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
1. Rennert-May E, Leal J, Thanh NX, Lang E, Dowling S, Manns B, et al. The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study. PLoS One . 2021;16(6 June):1–11.
2. Kuitunen I, Ponkilainen VT, Launonen AP, Reito A, Hevonkorpi TP, Paloneva J, et al. The effect of national lockdown due to COVID-19 on emergency department visits. Scand J Trauma Resusc Emerg Med. 2020;28(1):1–8.
3. Boserup B, McKenney M, Elkbuli A. The impact of the COVID-19 pandemic on emergency department visits and patient safety in the United States. Am J Emerg Med. 2020;38(January):1732–6.
4. Presiden Republik Indonesia. Peraturan Pemerintah Republik Indonesia Nomor 21 Tahun 2020 Tentang Pembatasan Sosial Berskala Besar Dalam Rangka Percepatan Penanganan Corona Virus Disease 19 (COVID-19). Kementeri Sekr Negara Republlik Indones [Internet]. 2020; Available from: https://peraturan.bpk.go.id/Home/Details/135059/pp-no-21-tahun-2020
5. Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in β-thalassemia. Blood Rev. 2019;37:100588.
6. Larasati SA, Riza M. Pengaruh Transfusi Sel Darah Merah Terhadap Perubahan Kadar Kalium pada Pasien Thalassemia Mayor. Sari Pediatr. 2020;21(4):241.
7. Ngo A, Masel D, Sbb A, Cahill C. Blood banking and transfusion medicine challenges during the COVID-19 pandemic. Clin Lab Med. 2020;40(4):587–601.
8. Stanworth SJ, New H V, Apelseth TO, Brunskill S, Cardigan R, Doree C, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7(10):756–64.
9. Cai X, Ren M, Chen F, Li L, Lei H, Wang X. Blood transfusion during the COVID-19 outbreak. Blood Transfus. 2020;18(2):79–85.
10. Vives Corrons JL, De Sanctis V. Rare anaemias, sickle-cell disease and covid-19. Acta Biomed. 2020;91(2):216–7.
11. Farmakis D, Triposkiadis F, Lekakis J, Parissis J. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management. Eur J Heart Fail. 2017;19(4):479–89.
12. Haley K. Congenital Hemolytic Anemia. Med Clin North Am [Internet]. 2017;101(2):361–74. Available from: http://dx.doi.org/10.1016/j.mcna.2016.09.008
13. Vilela T de S, Braga JAP, Loggetto SR. Hemoglobinopathy and pediatrics in the time of COVID-19. Hematol Transfus Cell Ther. 2021;43(1):87–100.
14. Malard F, Genthon A, Brissot E, van de Wyngaert Z, Marjanovic Z, Ikhlef S, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant. 2020; 55(11): 2180–4.
15. Chowdhury SF, Anwar S. Management of Hemoglobin Disorders During the COVID-19 Pandemic. Front Med. 2020;7(June):1–6.
16. Karimi M, Haghpanah S, Zarei T, Azarkeivan A, Shirkavand A, Matin S, et al. Prevalence and severity of coronavirus disease 2019 (COVID-19) in transfusion dependent and nontransfusion dependent β-thalassemia patients and effects of associated comorbidities: An iranian nationwide study. Acta Biomed. 2020;91(3):1–7.
17. Karimi M, De Sanctis V. Implications of SARSR-COV 2 infection in thalassemias: Do patients fall into the ‘high clinical risk’ category? Acta Biomed. 2020;91(2):50–6.
18. Noun P, Ibrahim A, Hodroj MH, Bou-Fakhredin R, Taher AT. COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals. Expert Rev Hematol. 2020;13(10):1081–92.
19. Motta I, Migone De Amicis M, Pinto VM, Balocco M, Longo F, Bonetti F, et al. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience. Am J Hematol. 2020;95(8):E198–9.
20. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7(January):19–21.
21. Noordin SS, Yusoff NM, Karim FA, Chong SE. Blood transfusion services amidst the COVID-19 pandemic. J Glob Health. 2021;11:1–6.
22. Al Mahmasani L, Hodroj MH, Finianos A, Taher A. COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications. Ann Hematol. 2021;100(5):1115–22.
23. Loua A, Kasilo OMJ, Nikiema JB, Sougou AS, Kniazkov S, Annan EA. Impact of the COVID-19 pandemic on blood supply and demand in the WHO African Region. Vox Sang. 2021;116(7):774–84.
24. Bouhou S, Benajiba M, Masrar A. The impact of the covid-19 pandemic on the continuity of transfusion care for thallasemic patients: A case report. Pan Afr Med J. 2021;38(33):1–8.
25. Trocado V, Silvestre-Machado J, Azevedo L, Miranda A, Nogueira-Silva C. Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes. J Matern Neonatal Med. 2020;0(0):1–13.
26. Hailan YMA, Sayed G, Yassin MA. COVID-19 in a pregnant patient with beta-thalassemia major: A case report. Clin Case Reports. 2021;9(7):1–5.
27. Dehshal MH, Hosoya S, Bahremani FH, Namini MT, Eleftheriou A. COVID-19 and Thalassaemia in Iran. Thalass Reports. 2020;10(1):9157.
28. Arshad Ali S, Azim D, Hassan HM, Iqbal A, Ahmed N, Kumar S, et al. The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience. Transfus Clin Biol. 2021;28(1):60–7.
2. Kuitunen I, Ponkilainen VT, Launonen AP, Reito A, Hevonkorpi TP, Paloneva J, et al. The effect of national lockdown due to COVID-19 on emergency department visits. Scand J Trauma Resusc Emerg Med. 2020;28(1):1–8.
3. Boserup B, McKenney M, Elkbuli A. The impact of the COVID-19 pandemic on emergency department visits and patient safety in the United States. Am J Emerg Med. 2020;38(January):1732–6.
4. Presiden Republik Indonesia. Peraturan Pemerintah Republik Indonesia Nomor 21 Tahun 2020 Tentang Pembatasan Sosial Berskala Besar Dalam Rangka Percepatan Penanganan Corona Virus Disease 19 (COVID-19). Kementeri Sekr Negara Republlik Indones [Internet]. 2020; Available from: https://peraturan.bpk.go.id/Home/Details/135059/pp-no-21-tahun-2020
5. Shah FT, Sayani F, Trompeter S, Drasar E, Piga A. Challenges of blood transfusions in β-thalassemia. Blood Rev. 2019;37:100588.
6. Larasati SA, Riza M. Pengaruh Transfusi Sel Darah Merah Terhadap Perubahan Kadar Kalium pada Pasien Thalassemia Mayor. Sari Pediatr. 2020;21(4):241.
7. Ngo A, Masel D, Sbb A, Cahill C. Blood banking and transfusion medicine challenges during the COVID-19 pandemic. Clin Lab Med. 2020;40(4):587–601.
8. Stanworth SJ, New H V, Apelseth TO, Brunskill S, Cardigan R, Doree C, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7(10):756–64.
9. Cai X, Ren M, Chen F, Li L, Lei H, Wang X. Blood transfusion during the COVID-19 outbreak. Blood Transfus. 2020;18(2):79–85.
10. Vives Corrons JL, De Sanctis V. Rare anaemias, sickle-cell disease and covid-19. Acta Biomed. 2020;91(2):216–7.
11. Farmakis D, Triposkiadis F, Lekakis J, Parissis J. Heart failure in haemoglobinopathies: pathophysiology, clinical phenotypes, and management. Eur J Heart Fail. 2017;19(4):479–89.
12. Haley K. Congenital Hemolytic Anemia. Med Clin North Am [Internet]. 2017;101(2):361–74. Available from: http://dx.doi.org/10.1016/j.mcna.2016.09.008
13. Vilela T de S, Braga JAP, Loggetto SR. Hemoglobinopathy and pediatrics in the time of COVID-19. Hematol Transfus Cell Ther. 2021;43(1):87–100.
14. Malard F, Genthon A, Brissot E, van de Wyngaert Z, Marjanovic Z, Ikhlef S, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant. 2020; 55(11): 2180–4.
15. Chowdhury SF, Anwar S. Management of Hemoglobin Disorders During the COVID-19 Pandemic. Front Med. 2020;7(June):1–6.
16. Karimi M, Haghpanah S, Zarei T, Azarkeivan A, Shirkavand A, Matin S, et al. Prevalence and severity of coronavirus disease 2019 (COVID-19) in transfusion dependent and nontransfusion dependent β-thalassemia patients and effects of associated comorbidities: An iranian nationwide study. Acta Biomed. 2020;91(3):1–7.
17. Karimi M, De Sanctis V. Implications of SARSR-COV 2 infection in thalassemias: Do patients fall into the ‘high clinical risk’ category? Acta Biomed. 2020;91(2):50–6.
18. Noun P, Ibrahim A, Hodroj MH, Bou-Fakhredin R, Taher AT. COVID-19 in benign hematology: emerging challenges and special considerations for healthcare professionals. Expert Rev Hematol. 2020;13(10):1081–92.
19. Motta I, Migone De Amicis M, Pinto VM, Balocco M, Longo F, Bonetti F, et al. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience. Am J Hematol. 2020;95(8):E198–9.
20. Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7(January):19–21.
21. Noordin SS, Yusoff NM, Karim FA, Chong SE. Blood transfusion services amidst the COVID-19 pandemic. J Glob Health. 2021;11:1–6.
22. Al Mahmasani L, Hodroj MH, Finianos A, Taher A. COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications. Ann Hematol. 2021;100(5):1115–22.
23. Loua A, Kasilo OMJ, Nikiema JB, Sougou AS, Kniazkov S, Annan EA. Impact of the COVID-19 pandemic on blood supply and demand in the WHO African Region. Vox Sang. 2021;116(7):774–84.
24. Bouhou S, Benajiba M, Masrar A. The impact of the covid-19 pandemic on the continuity of transfusion care for thallasemic patients: A case report. Pan Afr Med J. 2021;38(33):1–8.
25. Trocado V, Silvestre-Machado J, Azevedo L, Miranda A, Nogueira-Silva C. Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes. J Matern Neonatal Med. 2020;0(0):1–13.
26. Hailan YMA, Sayed G, Yassin MA. COVID-19 in a pregnant patient with beta-thalassemia major: A case report. Clin Case Reports. 2021;9(7):1–5.
27. Dehshal MH, Hosoya S, Bahremani FH, Namini MT, Eleftheriou A. COVID-19 and Thalassaemia in Iran. Thalass Reports. 2020;10(1):9157.
28. Arshad Ali S, Azim D, Hassan HM, Iqbal A, Ahmed N, Kumar S, et al. The impact of COVID-19 on transfusion-dependent thalassemia patients of Karachi, Pakistan: A single-center experience. Transfus Clin Biol. 2021;28(1):60–7.